A. Michael Lincoff, M.D., FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Sanofi-aventis(SIGNIFICANT), Abbott(SIGNIFICANT), Sarepta(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Johnson & Johnson(SIGNIFICANT), Cardiovascular Systems(SIGNIFICANT), Novartis(SIGNIFICANT), Edwards Lifesciences(SIGNIFICANT), Juventas(SIGNIFICANT), Medtronic(SIGNIFICANT), Orexigen(SIGNIFICANT), Amgen(SIGNIFICANT), Medicines Comapny(SIGNIFICANT), CSL Behring(SIGNIFICANT), Covidien(SIGNIFICANT), Janssen(SIGNIFICANT), Astra Zeneca(SIGNIFICANT), Lilly(SIGNIFICANT), Pfizer(SIGNIFICANT), Takeda(SIGNIFICANT), Ethicon(SIGNIFICANT), Esperion(SIGNIFICANT), Cerenis(SIGNIFICANT), Infraredx(SIGNIFICANT)

View Full Disclosure